4[4]Richard JH,William DM,Martin JS,et al.A dialysis modality decision guide based On the experience of six dialysis centers[J].Dialysis & Transplantation,1990,19(2):66-69.
5[5]Maiorca R,Vonesh E,Cancarini GC,et al.A six-year comparison of patient and technique survivals in CAPD and HD[J].Kidney Int,1988,34(4):518-524.
6[6]Nisscnson AR,Prichard SS,Cheng IK,et al.ESRD modality selection into the 21st century:the importance of non medical factors[J].ASAIO J,1997,43(3):143-150.
7[8]Brenner FP,Hortal P,et al.Morbidity and mortality of disease paticnts on dialysis in a 10-years program:Value of combined treatment[J].Med Clin Barc,1989;14(92):10.
8[9]Klamma HE,Fancis JO,Rosenthal GD.Cost-effectiveness analysisapplied to the treatment of chronic renal disease[J].Med Care,1968,6(1):48-54.
9[10]Churchill DN,lemon BC,Torrance GW.A cost-effectiveness analysis of continuous ambulatory peritoneal dialysis and hospital hemodialysis[J].Medi Decis Making,1984,4(4):489-500.
10[11]Gamer TI,Dardis R.Cost-effectiveness analysis of end-stage renal disease treatment[J].Med Care,1987,25(1):25-34.
7Horl Wit, deAlvaro F, Williams PF. Healthcare systems and end-stage renal disease(ESRD) therapies-an international review: access to ESRD treatments. Nephrol Dial Transplant, 1999,14:10.
8Gokal R, Figueras M, Olie A, et al. Outcomes in peritoneal dialysis and haemodialysis: a compsistive assesment of survival and quality of life.Nephrol Dial Transplant, 1999,14:24.
9Allen RN, Sarah SP, Ignatius KP,et al.ESRD modality selection into the 21st century:the importance of non medical factors. ASAIO Journal,1997.
10Eric T. Edgell . A Review of Health-Related Quality-of-Life Measures Used in End-Stage Renal Disease. Clinical Therapeutics,1996, 5(18): 887-938.
